It’s a race to a moving finish line. People around the globe are lining up to get vaccinated as new variants of the coronavirus evolve and spread. Scientists continue their tireless work behind the scenes to find new vaccines and boosters to help avoid future infections from coronaviruses and other pathogens.
3M Corporate Research Materials Lab Scientists Mark Tomai, Ph.D. (immunologist), and George Griesgraber, Ph.D. (synthetic chemist), recently sat down with the American Chemical Society (ACS) to talk about a small molecule, or adjuvant, developed by their team at 3M. This 3M-052 adjuvant may help in the fight to vaccinate against SARS-CoV2 and other illnesses, including HIV.
We’ll send a roundup of our science and innovation stories each quarter.
Your form was submitted successfully!
An error has occurred while submitting. Please try again later...